Medical Device User Fee Amendments; Public Meeting; Request for Comments
FDA announces a public meeting on Medical Device User Fee Amendments, which may indirectly affect cosmetics firms that also manufacture or distribute medical devices or combination products. No direct MoCRA impact.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 8, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Indie beauty brands, contract manufacturers, private-label makers, importers/distributors that also deal with medical devices or combination products (e.g., cosmetic devices, drug-device combos). should confirm how it applies to their specific situation before acting. There is a time constraint attached: Comments due as specified in the Federal Register notice (check document for exact date).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA is seeking comments on proposed recommendations for Medical Device User Fee Amendments. This does not change any MoCRA requirements.
Who it affects
Indie beauty brands, contract manufacturers, private-label makers, importers/distributors that also deal with medical devices or combination products (e.g., cosmetic devices, drug-device combos).
What you must do
Review if your business handles medical devices; if so, consider submitting comments by the deadline. Otherwise, no action needed.
Deadline
Comments due as specified in the Federal Register notice (check document for exact date).
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- Modification of Certain Terminology in Title 21
- Sterigenics U.S., LLC; Filing of Food Additive Petition
- FTC Issues Report to Congress on Adoption Practices
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor
- New Jersey bans some products with toxic PFAS chemicals. Here’s what to know - WHYY